• Home>
  • Stocks>
  • J B Chemicals & Pharmaceuticals Ltd Share Price
J B Chemicals & Pharmaceuticals Ltd share price logo

J B Chemicals & Pharmaceuticals Ltd Share Price

(JBCHEPHARM)

Small Cap

Healthcare Sector

Check the latest share price of J B Chemicals & Pharmaceuticals Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹1585.5

▲0.93%

as on 04:01PM, 29 Apr 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

J B Chemicals & Pharmaceuticals Ltd Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹1,575
    Day's Price Range
    ₹1,600.4

  • 52 Week's Low

    52 Week's High

    ₹1,385.75
    52-Week Price Range
    ₹2,030
1 Month Return+ 3.24 %
3 Month Return-10.99 %
1 Year Return-12.81 %
Previous Close₹1,600.40
Open₹1,600.40
Volume1.49L
Upper Circuit-
Lower Circuit-
Market Cap₹24,466.23Cr

J B Chemicals & Pharmaceuticals Ltd Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹24,466.23 Cr

Return on Equity (ROE)

18.46

Return on capital employed (ROCE)

23.61

P/B Ratio

5.79

Dividend Yield

1.05

EPS (TTM)

49.95

Sector

Pharmaceuticals

How to invest in J B Chemicals & Pharmaceuticals Ltd

Investing in J B Chemicals & Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for J B Chemicals & Pharmaceuticals Ltd or JBCHEPHARM on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of J B Chemicals & Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like J B Chemicals & Pharmaceuticals Ltd with just a few clicks!

J B Chemicals & Pharmaceuticals Ltd Valuation

Track how the P/E of J B Chemicals & Pharmaceuticals Ltd has moved over time to understand valuation trends.

J B Chemicals & Pharmaceuticals Ltd in the last 5 years

  • Overview

  • Trends

Lowest (10.61x)

October 24, 2019

Today (52.89x)

December 15, 2023

Industry (58.33x)

December 15, 2023

Highest (61.20x)

September 14, 2023

LowHigh

Today’s Price to Earnings Ratio: 52.89x

Analysts Recommendation on J B Chemicals & Pharmaceuticals Ltd

Get updated buy, sell, and hold recommendations by analysts on J B Chemicals & Pharmaceuticals Ltd.

based on 11 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

75% of analysts recommend a 'BUY' rating for J B Chemicals & Pharmaceuticals Ltd. Average target of ₹1465.27

Source: S&P Global Market Intelligence

Analysts Forecast on J B Chemicals & Pharmaceuticals Ltd

Get share price movements and forecasts by analysts on J B Chemicals & Pharmaceuticals Ltd.

J B Chemicals & Pharmaceuticals Ltd price forecast by 11 analysts

Downside of-6.77%

High

₹1657

Target

₹1465.27

Low

₹1137.5

J B Chemicals & Pharmaceuticals Ltd target price ₹1465.27, a slight downside of -6.77% compared to current price of ₹1585.5. According to 11 analysts rating.

Source: S&P Global Market Intelligence

J B Chemicals & Pharmaceuticals Ltd Financials

Get the annual and quarterly financial summary of J B Chemicals & Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'2 23Q'3 23Q'4 23Q'1 24Q'2 24
Revenue₹896.20Cr (-)₹881.74Cr (↓1.61%)₹844.51Cr (↓4.22%)₹861.73Cr (↑2.04%)₹1,004.40Cr (↑16.56%)
Net Income₹142.32Cr (-)₹150.59Cr (↑5.81%)₹133.57Cr (↓11.30%)₹126.16Cr (↓5.55%)₹176.83Cr (↑40.16%)
Net Profit Margin15.88% (-)17.08% (↑7.56%)15.82% (↓7.38%)14.64% (↓7.46%)17.61% (↑20.29%)
Value in ₹ crore
Details2019202020212022
Total Assets₹1,798.24Cr (-)₹1,816.68Cr (↑1.03%)₹2,208.79Cr (↑21.58%)₹2,546.45Cr (↑15.29%)
Total Liabilities₹313.67Cr (-)₹371.39Cr (↑18.40%)₹402.33Cr (↑8.33%)₹442.78Cr (↑10.05%)
Value in ₹ crore
Details20182019202020212022
Operating Cash Flow₹115.87Cr (-)₹192.63Cr (↑66.25%)₹271.95Cr (↑41.18%)₹335.43Cr (↑23.34%)₹147.10Cr (↓56.15%)

J B Chemicals & Pharmaceuticals Ltd Index Inclusions

BSE 500

₹34,765.79

0 (▲0%)

Nifty Smallcap 250

₹15,639.70

0.21 (▲32.55%)

NIFTY PHARMA

₹21,676.65

-1.06 (▲-231.45%)

Nifty 500

₹0.00

0 (▲0%)

S&P BSE SmallCap Select

₹7,178.77

0 (▲0%)

BSE Healthcare

₹42,555.65

0 (▲0%)

BSE Small-Cap

₹48,193.46

0 (▲0%)

S&P BSE 250 SmallCap

₹6,257.98

0 (▲0%)

S&P BSE 400 MidSmallCap

₹11,171.57

0 (▲0%)

Nifty MNC

₹26,910.00

-0.05 (▲-12.7%)

Nifty MidSmallcap 400

₹18,431.30

0.21 (▲38.8%)

S&P BSE AllCap

₹10,471.31

0 (▲0%)

J B Chemicals & Pharmaceuticals Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in J B Chemicals & Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
53.93%
0.00
Foreign Institutions
8.63%
0.00
Mutual Funds
16.17%
0.00
Retail Investors
18.36%
0.00
Others
2.92%
0.00

J B Chemicals & Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of J B Chemicals & Pharmaceuticals Ltd with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
J B Chemicals & Pharmaceuticals Ltd
J B Chemicals & Pharmaceuticals Ltd
BUY₹24,466.23 Cr101.74%0.52NANA
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹29,264.79 Cr142.95%0.53NANA
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
NA₹14,628.52 Cr41.85%0.64NANA
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹15,546.04 Cr48.01%0.73NANA
Poly Medicure Ltd
Poly Medicure Ltd
BUY₹21,699.41 Cr158.35%0.55NANA
See all

J B Chemicals & Pharmaceuticals Ltd News & Key Events

Latest news and events at one place to help you take investing decisions in J B Chemicals & Pharmaceuticals Ltd.

  • J B Chemicals Faces Challenges Amid Buy Call - 25 Apr, 2025

    JM Financial has a buy call on J B Chemicals with a target price of Rs 2,225. However, potential suspension of Ranitidine could impact revenues by 5-6%. The company reported a net profit of Rs 162.49 crore for the latest quarter.

  • JB Chemicals Schedules Investor Call for Q4 Results - 23 Apr, 2025

    JB Chemicals & Pharmaceuticals Ltd. has announced a conference call on May 15, 2025, to discuss its fourth-quarter results and future outlook, providing insights for investors and analysts.

  • J B Chemicals Shows Strong Financial Performance - 19 Apr, 2025

    J B Chemicals & Pharmaceuticals Ltd boasts a market cap of Rs 24,510 crores, with a 5-year stock return of 475.53%. The company reports a 19.03% return on equity, 5-year CAGR net profit growth of 23.29%, and revenue growth of 16.22%.

  • J B Chemicals Receives USFDA Approval for Generic Drug - 18 Apr, 2025

    J B Chemicals & Pharmaceuticals has received USFDA approval to market Bisoprolol tablets, a generic version of Teva's Zebeta, for treating hypertension.

  • J B Chemicals Approves Investment in Renewable Energy - 15 Apr, 2025

    J B Chemicals & Pharmaceuticals Ltd has approved the acquisition of up to 70 lakh equity shares of Jamnagar Renewables One Pvt. for Rs 7 crore. This investment aims to facilitate the consumption of power generated from a hybrid solar and wind power project.

Insights on J B Chemicals & Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 14.64% to 18.30% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 14.57% to 16.26% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.01K Cr → 971.49 Cr (in ₹), with an average decrease of 3.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 176.83 Cr → 162.49 Cr (in ₹), with an average decrease of 4.1% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 15.29% to 15.14% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 53.66% to 47.84% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, JBCHEPHARM stock has moved down by -3.4%

About J B Chemicals & Pharmaceuticals Ltd

J B Chemicals Pharmaceuticals, founded in 1976 in Maharastra, is a global player in pharmaceutical manufacturing. It manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, APIs, and agro-based products. It has subsidiaries in India and other countries and has been awarded the Certificate of Suitability to European Pharmacopoeia Monograph for Nifedipine EP from the European Directorate for Quality Medicines. It launched new products in the global market to expand its product portfolio and received approval from TGA Australia, USFDA, MCC South Africa, INVIMA Colombia, and MHRA UK. The company received the 'Most Trustworthy European Brand' by Readers Digest in cold and cough segment for the fourth consecutive year in 2003-04. It diverted into the contrast media products market during 2004-05 and entered agreements with PharmaaCare Pharmaceuticals and Ranbaxy Group for developing and marketing niche products in respective markets. It has undergone several mergers and diversifications in-order to increase its product range and profitability. More recently, it acquired a portfolio of brands from Sanzyme Private Limited and Azmarda brand from Novartis AG Switzerland. Thus, J B Chemicals Pharmaceuticals is well positioned to grow and progress further in the global pharmaceutical market.

Revenue: ₹1,004.40Cr as on June 2024 (Q2 24)
Net Profit: ₹176.83Cr as on June 2024 (Q2 24)
Listing date: 02 Feb, 1995
Chairperson Name: Ranjit Shahani.
OrganisationJ B Chemicals & Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Indian Mutual Funds that own J B Chemicals & Pharmaceuticals Ltd

Check out the Mutual Funds with significant holdings in J B Chemicals & Pharmaceuticals Ltd.

Futures and Options

View the latest movement in J B Chemicals & Pharmaceuticals Ltd Futures & Options, including strike prices, expiry dates, and percentage changes.

FAQs

What is J B Chemicals & Pharmaceuticals Ltd price today?

J B Chemicals & Pharmaceuticals Ltd share price today stands at ₹1585.5, Open: ₹1600.4, Previous Close: ₹1600.4, High: ₹1600.4, Low: ₹1575, 52 Week High: ₹2030, 52 Week Low: ₹1385.75.

How to Buy J B Chemicals & Pharmaceuticals Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy J B Chemicals & Pharmaceuticals Ltd shares

What are today's traded volumes of J B Chemicals & Pharmaceuticals Ltd?

Today's traded volume of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is 1.49L.

What is today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd?

Today's market capitalisation of J B Chemicals & Pharmaceuticals Ltd(JBCHEPHARM) is ₹24,466.23 Cr.

What is the 52 Week High and Low Range of J B Chemicals & Pharmaceuticals Ltd?

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM)
Price
52 Week High
₹2030
52 Week Low
₹1385.75

How much percentage J B Chemicals & Pharmaceuticals Ltd is down from its 52 Week High?

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price is ₹1585.5. It is down -21.90% from its 52 Week High price of ₹2030

How much percentage J B Chemicals & Pharmaceuticals Ltd is up from its 52 Week low?

J B Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) share price is ₹1585.5. It is up 14.41% from its 52 Week Low price of ₹1385.75